Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis
Introduction: Lung adenocarcinoma is the most common type of lung cancer and typically carries a high number of mutations. However, the genetic background of the tumors varies according to patients’ ethnic background and smoking status. Little data is available on the mutational landscape and the fr...
Main Authors: | Eva-Maria Talvitie, Lassi Liljeroos, Heikki Vilhonen, Katri Orte, Ilmo Leivo, Markku Kallajoki, Pekka Taimen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-10-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558622000598 |
Similar Items
-
New insights into the biology and development of lung cancer in never smokers—implications for early detection and treatment
by: Peiyao Wang, et al.
Published: (2023-08-01) -
Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas
by: Halide Nur URER, et al.
Published: (2023-05-01) -
SMARCA4 Mutations in Gastroesophageal Adenocarcinoma: An Observational Study via a Next-Generation Sequencing Panel
by: Kohei Yamashita, et al.
Published: (2024-03-01) -
Epidemiological characteristics and risk factors of lung adenocarcinoma: A retrospective observational study from North China
by: Daojuan Li, et al.
Published: (2022-08-01) -
Improved Prognostic Prediction in Never-Smoker Lung Cancer Patients by Integration of a Systemic Inflammation Marker with Tumor Immune Contexture Analysis
by: Massimo Milione, et al.
Published: (2020-07-01)